SCHEMBL723670

SCHEMBL723670

COC(=O)c1cc(OC(F)(F)F)cc(-c2ccnc3cc(-c4cc(OC)c(OC)c(OC)c4)oc23)c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE4C Q08493 3/20 0.41
LCLAT1 Q6UWP7 2/20 0.39
MAPT P10636 2/20 0.39
BRD4 O60885 4/20 0.38
RPS6KA2 Q15349 1/20 0.36
ACVR1 Q04771 1/20 0.36
ABL1 P00519 1/20 0.35
KDM4E B2RXH2 1/20 0.35
ALDH1A1 P00352 1/20 0.35
CYP3A4 P08684 1/20 0.35
CYP2C9 P11712 1/20 0.35
HPGD P15428 1/20 0.35
CYP2C19 P33261 1/20 0.35
IGF1R P08069 1/20 0.35
PTPN1 P18031 1/20 0.35
CSNK1D P48730 1/20 0.35
TUBB4A P04350 1/20 0.35
TUBB P07437 1/20 0.35
TUBA3C P0DPH7 1/20 0.35
TUBA1B P68363 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL724824 0.93 PDE4C (0.41) PDE4CLCLAT1MAPTBRD4RPS6KA2
SCHEMBL724951 0.88 PDE4C (0.42) PDE4CMAPTBRD4ACVR1KDM4E
SCHEMBL723532 0.88 PDE4C (0.40) PDE4CBRD4ABL1KDM4EALDH1A1
SCHEMBL721628 0.86 PDE4C (0.42) PDE4CBRD4ALDH1A1CYP3A4
SCHEMBL723485 0.84 PDE4C (0.39) PDE4CMAPTBRD4ALDH1A1CYP2C9
SCHEMBL723893 0.84 TAS1R3 (0.38) PDE4CLCLAT1MAPTBRD4KDM4E
SCHEMBL721518 0.84 PDE4C (0.43) PDE4CMAPTBRD4ALDH1A1CYP3A4
SCHEMBL724085 0.83 PDE4C (0.45) PDE4CBRD4HPGD
SCHEMBL10268115 0.83 PDE4C (0.45) PDE4CBRD4ALDH1A1CYP3A4TUBB4A
SCHEMBL723093 0.80 PDE4C (0.55) PDE4CBRD4KDM4EALDH1A1CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2609100-B1 FUROPYRIDINE DERIVATIVES MERCK PATENT GMBH (DE) 2015-06-24 EP claimed
US-9006440-B2 Furopyridine derivatives MERCK PATENT GMBH (DE) 2015-04-14 US claimed
US-20130225569-A1 FUROPYRIDINE DERIVATIVES MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 2013-08-29 US claimed
EP-2609100-A2 FUROPYRIDINE DERIVATIVES Merck Patent GmbH (DE) 2013-07-03 EP claimed
CN-103052640-A Furopyridine derivatives MERCK PATENT GMBH 2013-04-17 CN claimed
WO-2012025187-A2 FUROPYRIDINE DERIVATIVES MERCK PATENT GMBH (DE) 2012-03-01 WO claimed
EP-2609100-B1 FUROPYRIDINE DERIVATIVES MERCK PATENT GMBH (DE) 2015-06-24 EP disclosed
EP-2609100-B1 FUROPYRIDINE DERIVATIVES MERCK PATENT GMBH (DE) 2015-06-24 EP disclosed
US-9006440-B2 Furopyridine derivatives MERCK PATENT GMBH (DE) 2015-04-14 US disclosed
US-9006440-B2 Furopyridine derivatives MERCK PATENT GMBH (DE) 2015-04-14 US disclosed
WO-2012025187-A2 FUROPYRIDINE DERIVATIVES MERCK PATENT GMBH (DE) 2012-03-01 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130225569-A1 FUROPYRIDINE DERIVATIVES SYK, FCGRT, SSB PDE4C 2858/4885LCLAT1 526/4885MAPT 4861/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.